Biogen IDEC Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (65)

Latest Posts

About This Stock More About This Stock
Week In Review: How Trump's Policies Moved Stocks - Jan. 20
Article By: The Fly
Sunday, January 20, 2019 11:34 PM EST
Companies begin to see impact from shutdown, Grassley sees Trump proceeding with tariffs on imported cars
In this article: AUG, AXL, BWA, CMRE, DAC, DLPH, F, GM, HMC, KBH, LEA, LEN, MGA, NM, PHM, TEN, TGH, TM, VC, ADNT, DDAIF, NSANY, VLKAY, DCIX, Z, BIIB, CELG, EXPD, FCAU, ZG, RLGY, AIMT, RDFN, APTV
Read
Goldman Sachs: 4 Killer Stock Picks For 2019 (Part II)
Article By: TipRanks
Thursday, December 6, 2018 10:15 AM EST
Goldman Sachs has just released a report that highlights exactly the kind of stocks you want to be thinking about right now.
In this article: V, BIIB, DLTR, BKNG
Read
Week In Review: Alphamab Closes $100 Million Series A For Oncology Candidates
Article By: ChinaBio® Today
Saturday, November 24, 2018 4:09 PM EST
Alphamab Oncology, a clinical-stage Suzhou biopharma, completed a Series A funding with over $100 million in capital. Earlier this year, Alphamab Oncology was spun out of Suzhou Alphamab with seven oncology assets and related technology platforms.
In this article: LLY, CASI, BIIB, GILD
Read
3 Drug/Biotech Stocks In Focus On World Alzheimer's Day
Article By: Zacks Investment Research
Friday, September 21, 2018 2:57 PM EST
Here we take a look at companies with promising candidates in their pipeline for Alzheimer’s Disease (AD).
In this article: RHHBY, BIIB Also: AGN
Read
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By: Zacks Investment Research
Sunday, August 12, 2018 4:27 PM EST
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
In this article: IBB, AMGN, GILD, BBH, FBT, ALXN, BIIB
Read

PARTNER HEADLINES

Latest Tweets for $BIIB

No tweets yet!

$BIIB

Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink
Craig Newman 11/24/2016 5:28:00 AM

What are the chances of $BIIB and $TSRO being bought out? They have long been targets, or at least rumored to be, for consolidation.

1 to 1 of 1 comments